You are here: Industry Insights > COVID-19

News List

COVID-19 therapeutics to rely on large-scale biomanufacturing reactors, report says europeanpharmaceuticalreview
November 12, 2020
A new report has found that if COVID-19 biologics are approved, it could apply pressure to the global biomanufacturing capacity.
European Commission approves contract with BioNTech-Pfizer alliance worldpharmanews
November 12, 2020
Yesterday, the European Commission approved a fourth contract with pharmaceutical companies BioNTech and Pfizer, which provides for the initial purchase of 200 million doses on behalf of all EU Member States, plus an option to request up to a further ...
Mallinckrodt launches retrospective study for inhaled therapy in COVID-19 pharmatimes
November 12, 2020
Mallinckrodt has launched a retrospective chart review study which will collect real-world data on the use of INOmax (nitric oxide) gas for inhalation therapy in patients with respiratory complications associated with COVID-19.
Senhwa Announces IND Submissions for Silmitasertib for COVID-19 americanpharmaceuticalreview
November 12, 2020
Senhwa Biosciences has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to evaluate its investigational drug Silmitasertib for the treatment of severe Coronavirus Disease 2019 (COVID-19).
Adagio Therapeutics raises funding to advance Covid-19 antibodies pharmaceutical-technology
November 12, 2020
Adagio Therapeutics has raised $80m in funding to further advance best-in-class antibodies to both treat and protect against Covid-19.
Altimmune Adds Lonza as Mfg. Partner for Supply of AdCOVID contractpharma
November 12, 2020
Single-dose intranasal vaccine for COVID-19 designed to generate a broad immune response with nasal mucosal immunity to prevent infection and transmission.
Pfizer, BioNTech to Supply 200M Doses of BNT162b2 to EU contractpharma
November 12, 2020
Deliveries are anticipated to start by the end of 2020, subject to clinical success and regulatory authorization.
Sputnik V vaccine shows 92 per cent efficacy in ongoing phase III trials in Russia expresspharma
November 12, 2020
The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical trials in Russia involving 40,000 volunteers.
COVID-19 forced pharma to shuffle technology investment priorities: GlobalData expresspharma
November 12, 2020
Social media and cloud computing became the most dominant technologies for current investments for pharma in 2020.
cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour prnasia
November 11, 2020
Following GenScript Biotech Corporation's cPass? SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA) Singapore on 8th May 2020, CE-IVD marking in Europe on 26th May 2020 and FDA ...